SCHEMBL7019161

SCHEMBL7019161

Sc1ccc2occc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.50
DYRK1A Q13627 5/20 0.47
CDK9 P50750 1/20 0.46
HTR1B P28222 5/20 0.41
EPM2A O95278 1/20 0.41
PTPRC P08575 1/20 0.41
PTPN6 P29350 1/20 0.41
CDC14A Q9UNH5 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
CTNNB1 P35222 2/20 0.40
WNT3A P56704 2/20 0.40
KDM4E B2RXH2 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
NFKB1 P19838 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19914471 0.81 CYP2A6 (0.44) CYP2A6DYRK1ACDK9HTR1BKDM4E
SCHEMBL2008439 0.76 CYP2A6 (0.50) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL2149910 0.73 CYP2A6 (0.54) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL12319505 0.71 CYP2A6 (0.50) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL320843 0.71 DYRK1A (0.55) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL276359 0.71 CYP2A6 (0.55) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL6733 0.71 CYP2A6 (0.50) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL826762 0.71 CYP2A6 (0.50) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL317485 0.71 CYP2A6 (0.50) CYP2A6DYRK1ACDK9HTR1BEPM2A
SCHEMBL172397 0.71 CTNNB1 (0.54) CYP2A6DYRK1ACDK9HTR1BCTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257395-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2023-08-17 US disclosed
US-20210253593-A1 SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-08-19 US disclosed
WO-2020223551-A1 INHIBITING OTUB1 INTEGRAL EARLY DISCOVERY, INC. (US) 2020-11-05 WO disclosed
WO-2018039621-A1 INHIBITION OF OLIG2 ACTIVITY Curtana Pharmaceuticals, Inc. (US) 2018-03-01 WO disclosed
US-20110124578-A1 AMINO ACID INHIBITORS OF CYTOCHROME P450 SEQUOIA PHARMACEUTICALS INC. (US) 2011-05-26 US disclosed
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124578-A1 AMINO ACID INHIBITORS OF CYTOCHROME P450 CYP3A43, CYP7A1, CYP3A5 CYP2A6 17/4885DYRK1A 2762/4885CDK9 730/4885
US-20230257395-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS TRPA1, TRPV1, TRPV5 CYP2A6 3564/4885DYRK1A 1894/4885CDK9 1936/4885
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH CYP2A6 455/4885DYRK1A 3009/4885CDK9 2826/4885
US-20210253593-A1 SUBSTITUTED INDOLE COMPOUNDS TLR7, TLR1, HTR7 CYP2A6 1774/4885DYRK1A 1896/4885CDK9 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.